1. Home
  2. PII vs MRUS Comparison

PII vs MRUS Comparison

Compare PII & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PII
  • MRUS
  • Stock Information
  • Founded
  • PII 1954
  • MRUS 2003
  • Country
  • PII United States
  • MRUS Netherlands
  • Employees
  • PII N/A
  • MRUS N/A
  • Industry
  • PII Recreational Games/Products/Toys
  • MRUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PII Consumer Discretionary
  • MRUS Health Care
  • Exchange
  • PII Nasdaq
  • MRUS Nasdaq
  • Market Cap
  • PII 3.8B
  • MRUS 3.6B
  • IPO Year
  • PII 1987
  • MRUS 2016
  • Fundamental
  • Price
  • PII $66.84
  • MRUS $46.58
  • Analyst Decision
  • PII Buy
  • MRUS Strong Buy
  • Analyst Count
  • PII 12
  • MRUS 10
  • Target Price
  • PII $85.00
  • MRUS $86.70
  • AVG Volume (30 Days)
  • PII 904.7K
  • MRUS 376.4K
  • Earning Date
  • PII 10-22-2024
  • MRUS 10-31-2024
  • Dividend Yield
  • PII 3.95%
  • MRUS N/A
  • EPS Growth
  • PII N/A
  • MRUS N/A
  • EPS
  • PII 3.57
  • MRUS N/A
  • Revenue
  • PII $7,803,200,000.00
  • MRUS $35,932,000.00
  • Revenue This Year
  • PII N/A
  • MRUS N/A
  • Revenue Next Year
  • PII $1.03
  • MRUS $52.49
  • P/E Ratio
  • PII $18.73
  • MRUS N/A
  • Revenue Growth
  • PII N/A
  • MRUS N/A
  • 52 Week Low
  • PII $66.06
  • MRUS $22.26
  • 52 Week High
  • PII $100.91
  • MRUS $61.61
  • Technical
  • Relative Strength Index (RSI)
  • PII 31.02
  • MRUS 32.37
  • Support Level
  • PII $66.06
  • MRUS $48.42
  • Resistance Level
  • PII $68.59
  • MRUS $53.49
  • Average True Range (ATR)
  • PII 1.99
  • MRUS 2.17
  • MACD
  • PII -0.15
  • MRUS -0.54
  • Stochastic Oscillator
  • PII 8.98
  • MRUS 5.73

About PII Polaris Inc.

Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, including motorcycles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to another segment of the outdoor lifestyle market. Polaris products retailed through more than 2,500 dealers in North America and through 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Share on Social Networks: